| Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways RP Nair, KC Duffin, C Helms, J Ding, PE Stuart, D Goldgar, ... Nature genetics 41 (2), 199-204, 2009 | 1639 | 2009 |
| Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity LC Tsoi, SL Spain, J Knight, E Ellinghaus, PE Stuart, F Capon, J Ding, ... Nature genetics 44 (12), 1341-1348, 2012 | 1096 | 2012 |
| An autoinflammatory disease with deficiency of the interleukin-1–receptor antagonist I Aksentijevich, SL Masters, PJ Ferguson, P Dancey, J Frenkel, ... New England Journal of Medicine 360 (23), 2426-2437, 2009 | 1058 | 2009 |
| Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial IB McInnes, PJ Mease, B Kirkham, A Kavanaugh, CT Ritchlin, P Rahman, ... The Lancet 386 (9999), 1137-1146, 2015 | 1037 | 2015 |
| Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility Australo-Anglo-American Spondyloarthritis Consortium (TASC), ... Nature genetics 43 (8), 761-767, 2011 | 985 | 2011 |
| Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial IB McInnes, A Kavanaugh, AB Gottlieb, L Puig, P Rahman, C Ritchlin, ... The Lancet 382 (9894), 780-789, 2013 | 917 | 2013 |
| Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis PJ Mease, IB McInnes, B Kirkham, A Kavanaugh, P Rahman, ... New England Journal of Medicine 373 (14), 1329-1339, 2015 | 889 | 2015 |
| Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci Groupe Française d'Etude Génétique des Spondylarthrites (GFEGS), ... Nature genetics 45 (7), 730-738, 2013 | 778 | 2013 |
| Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological … C Ritchlin, P Rahman, A Kavanaugh, IB McInnes, L Puig, S Li, Y Wang, ... Annals of the rheumatic diseases 73 (6), 990-999, 2014 | 734 | 2014 |
| Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised … P Nash, B Kirkham, M Okada, P Rahman, B Combe, GR Burmester, ... The Lancet 389 (10086), 2317-2327, 2017 | 459 | 2017 |
| Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 E Ellinghaus, D Ellinghaus, PE Stuart, RP Nair, S Debrus, JV Raelson, ... Nature genetics 42 (11), 991-995, 2010 | 433 | 2010 |
| Genetic epidemiology of psoriasis and psoriatic arthritis P Rahman, JT Elder Annals of the rheumatic diseases 64 (suppl 2), ii37-ii39, 2005 | 415 | 2005 |
| Accrual of organ damage over time in patients with systemic lupus erythematosus. DD Gladman, MB Urowitz, P Rahman, D Ibañez, LS Tam The Journal of rheumatology 30 (9), 1955-1959, 2003 | 414 | 2003 |
| Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis CT Jordan, L Cao, EDO Roberson, S Duan, CA Helms, RP Nair, KC Duffin, ... The American Journal of Human Genetics 90 (5), 796-808, 2012 | 404 | 2012 |
| Genome-wide association analysis identifies three psoriasis susceptibility loci PE Stuart, RP Nair, E Ellinghaus, J Ding, T Tejasvi, JE Gudjonsson, Y Li, ... Nature genetics 42 (11), 1000-1004, 2010 | 403 | 2010 |
| Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological … D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ... The Lancet 392 (10163), 2441-2451, 2018 | 380 | 2018 |
| Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants LC Tsoi, PE Stuart, C Tian, JE Gudjonsson, S Das, M Zawistowski, ... Nature communications 8 (1), 15382, 2017 | 364 | 2017 |
| Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus P Rahman, DD Gladman, MB Urowitz, D Hallett, LS Tam Lupus 10 (2), 93-96, 2001 | 351 | 2001 |
| Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial PJ Mease, P Rahman, AB Gottlieb, AP Kollmeier, EC Hsia, XL Xu, ... The Lancet 395 (10230), 1126-1136, 2020 | 344 | 2020 |
| Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture PE Stuart, RP Nair, LC Tsoi, T Tejasvi, S Das, HM Kang, E Ellinghaus, ... The American Journal of Human Genetics 97 (6), 816-836, 2015 | 340 | 2015 |
